- Home
- DINO vs RGEN Comparison
DINO vs RGEN Comparison
Compare DINO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DINO
- RGEN
- Stock Information
- Founded
- DINO 1947
- RGEN 1981
- Country
- DINO United States
- RGEN United States
- Employees
- DINO N/A
- RGEN N/A
- Industry
- DINO Oil & Gas Production
- RGEN Medical/Dental Instruments
- Sector
- DINO Energy
- RGEN Health Care
- Exchange
- DINO Nasdaq
- RGEN Nasdaq
- Market Cap
- DINO 9.0B
- RGEN 8.2B
- IPO Year
- DINO N/A
- RGEN N/A
- Fundamental
- Price
- DINO $45.00
- RGEN $141.78
- Analyst Decision
- DINO Buy
- RGEN Buy
- Analyst Count
- DINO 10
- RGEN 10
- Target Price
- DINO $61.33
- RGEN $188.38
- AVG Volume (30 Days)
- DINO 2.2M
- RGEN 926.2K
- Earning Date
- DINO 10-31-2024
- RGEN 10-29-2024
- Dividend Yield
- DINO 4.51%
- RGEN N/A
- EPS Growth
- DINO N/A
- RGEN N/A
- EPS
- DINO 6.22
- RGEN N/A
- Revenue
- DINO $31,438,583,000.00
- RGEN $602,354,000.00
- Revenue This Year
- DINO N/A
- RGEN $0.08
- Revenue Next Year
- DINO N/A
- RGEN $12.97
- P/E Ratio
- DINO $7.11
- RGEN N/A
- Revenue Growth
- DINO N/A
- RGEN N/A
- 52 Week Low
- DINO $44.07
- RGEN $110.45
- 52 Week High
- DINO $64.16
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- DINO 40.95
- RGEN 43.50
- Support Level
- DINO $44.07
- RGEN $138.80
- Resistance Level
- DINO $46.40
- RGEN $150.72
- Average True Range (ATR)
- DINO 1.32
- RGEN 4.98
- MACD
- DINO -0.22
- RGEN -0.92
- Stochastic Oscillator
- DINO 17.24
- RGEN 24.50
About DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.